CAS: 941690-55-7 - 3-[(Methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]-4-quinolinecarboxamide

Formel: C₂₆H₂₅N₃O₃S

InChl: InChI=1S/C26H25N3O3S/c1-3-21(18-12-6-4-7-13-18)28-26(30)23-20-16-10-11-17-22(20)27-24(19-14-8-5-9-15-19)25(23)29-33(2,31)32/h4-17,21,29H,3H2,1-2H3,(H,28,30)/t21-/m0/s1

InChI Key: InChIKey=QYTBBBAHNIWFOD-NRFANRHFSA-N

SMILES: O=C(NC(C=1C=CC=CC1)CC)C=2C=3C=CC=CC3N=C(C=4C=CC=CC4)C2NS(=O)(=O)C

Synonyme:

• Pavinetant
• 3-[(Methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]-4-quinolinecarboxamide
• 4-Quinolinecarboxamide, 3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]-
• AZD 4901
• NK 3RA

MLE-4901

CAS: 941690-55-7

Applications MLE-4901, is a neurokinin-3 receptor (NK3R) antagonist. References Li, Y. et al.: Xenobiotica. 2010 …

• Formel: C₂₆H₂₅N₃O₃S
• Farbe und Form: Neat
• Molekulargewicht: 459.56

Pavinetant

CAS: 941690-55-7

Pavinetant (MLE-4901) is an orally available neurokinin-3 receptor (NK3R) antagonist used to improve menopausal symptoms.

• Formel: C₂₆H₂₅N₃O₃S
• Reinheit: 99.60%
• Farbe und Form: Solid
• Molekulargewicht: 459.56

Pavinetant

CAS: 941690-55-7

Pavinetant is a drug that interacts with the neurokinin-1 receptor. It is being studied as …

• Formel: C₂₆H₂₅N₃O₃S
• Reinheit: Min. 95%
• Molekulargewicht: 459.56 g/mol